We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATAQ
3326
DELISTED
Altimar Acquisition Corp III
ATAQ
-722,748
Closed -$7.28M
NSTC
3327
DELISTED
Northern Star Investment Corp. III
NSTC
-1,852,694
Closed -$18.6M
CCAI
3328
DELISTED
Cascadia Acquisition Corp. Class A Common Stock
CCAI
-723,914
Closed -$7.33M
FWAC
3329
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
-352,419
Closed -$3.54M
AGAC
3330
DELISTED
African Gold Acquisition Corp
AGAC
-2,009,992
Closed -$20.2M
ABST
3331
DELISTED
Absolute Software Corp
ABST
-30,792
Closed -$321K
VRAY
3332
DELISTED
ViewRay, Inc.
VRAY
-50,900
Closed -$228K
GGAA
3333
DELISTED
Genesis Growth Tech Acquisition Corp. Class A Ordinary Shares
GGAA
-149,998
Closed -$1.55M
ENTF
3334
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Class A Ordinary Shares
ENTF
-461,696
Closed -$4.75M
SDAC
3335
DELISTED
Sustainable Development Acquisition I Corp. Class A Common Stock
SDAC
-1,522,189
Closed -$15.3M
BGRY
3336
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
-150,000
Closed -$90K
FMIV
3337
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
-572,366
Closed -$5.75M
SCAQ
3338
DELISTED
Stratim Cloud Acquisition Corp. Class A Common Stock
SCAQ
-1,100,410
Closed -$11.1M
AZRE
3339
DELISTED
Azure Power Global Limited
AZRE
-71,644
Closed -$309K
HWKZ
3340
DELISTED
Hawks Acquisition Corp
HWKZ
-244,042
Closed -$2.44M
GOGN
3341
DELISTED
GoGreen Investments Corporation
GOGN
-1,234,951
Closed -$12.8M
DNAB
3342
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
-917,979
Closed -$9.24M
THCHW
3343
CALL
DELISTED
TH International Limited Warrant
THCHW
-77,124
Closed -$214K
JUGG
3344
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
-484,638
Closed -$4.87M
TOAC
3345
DELISTED
Talon 1 Acquisition Corp. Class A Ordinary Shares
TOAC
-732,148
Closed -$7.59M
RXDX
3346
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-48,777
Closed -$5.37M
LITT
3347
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
-1,262,336
Closed -$12.7M
CYXT
3348
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
-110,334
Closed -$212K
CS
3349
DELISTED
Credit Suisse Group
CS
-1,547,788
Closed -$4.71M
MTVC
3350
DELISTED
Motive Capital Corp II
MTVC
-1,583,457
Closed -$16.2M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.